ATAI
Atai Beckley N.V.
Key Financials
Revenue
$308000
↓ 1.9%
Net Income
$-149269000
↓ 271.1%
Operating Income
$-102691000
↑ 18.2%
Total Liabilities
$42.8M
↓ 12.9%
EPS (Diluted)
$-0.93
↓ 272.0%
Total Assets
$159.4M
↓ 45.7%
Shareholders' Equity
$116.3M
↓ 52.1%
Long-term Debt
$14.1M
↓ 6.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 144 | 3/20/2026 | View on SEC |
| 144 | 2/26/2026 | View on SEC |
| 15-12G | 12/31/2025 | View on SEC |
| POSASR | 12/31/2025 | View on SEC |
| S-8 POS | 12/31/2025 | View on SEC |
| 8-K | 12/5/2025 | View on SEC |
| 424B7 | 12/5/2025 | View on SEC |
| 4 | 11/26/2025 | View on SEC |
| 10-Q | 11/12/2025 | View on SEC |
| 8-K | 11/12/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ATAI |
| Company Name | Atai Beckley N.V. |
| CIK | 1840904 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | P7 |
| Phone | 49 89 2153 9035 |